X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ELDER PHARMA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD ELDER PHARMA ORCHID PHARMA LTD/
ELDER PHARMA
 
P/E (TTM) x -0.2 -0.2 - View Chart
P/BV x 0.2 0.1 157.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA LTD   ELDER PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ELDER PHARMA
Jun-14
ORCHID PHARMA LTD/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs194380 51.1%   
Low Rs35188 18.6%   
Sales per share (Unadj.) Rs276.5491.2 56.3%  
Earnings per share (Unadj.) Rs-79.2-3.2 2,489.6%  
Cash flow per share (Unadj.) Rs-43.514.4 -301.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.9376.5 14.3%  
Shares outstanding (eoy) m70.4520.54 343.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.40.6 71.6%   
Avg P/E ratio x-1.4-89.3 1.6%  
P/CF ratio (eoy) x-2.619.7 -13.4%  
Price / Book Value ratio x2.10.8 281.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0675,833 138.3%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5272,179 116.0%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,47710,089 193.1%  
Other income Rs m407257 158.7%   
Total revenues Rs m19,88410,346 192.2%   
Gross profit Rs m1,103-792 -139.2%  
Depreciation Rs m2,519361 697.3%   
Interest Rs m5,2272,756 189.6%   
Profit before tax Rs m-6,236-3,653 170.7%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5113,713 13.8%   
Tax Rs m-125125 -100.0%   
Profit after tax Rs m-5,580-65 8,539.1%  
Gross profit margin %5.7-7.8 -72.1%  
Effective tax rate %2.0-3.4 -58.6%   
Net profit margin %-28.7-0.6 4,423.2%  
BALANCE SHEET DATA
Current assets Rs m11,0149,240 119.2%   
Current liabilities Rs m32,0609,998 320.7%   
Net working cap to sales %-108.1-7.5 1,438.8%  
Current ratio x0.30.9 37.2%  
Inventory Days Days9546 204.9%  
Debtors Days Days3460 56.0%  
Net fixed assets Rs m29,44010,124 290.8%   
Share capital Rs m705206 342.5%   
"Free" reserves Rs m2,0435,582 36.6%   
Net worth Rs m3,8007,734 49.1%   
Long term debt Rs m9,0184,889 184.5%   
Total assets Rs m46,51022,882 203.3%  
Interest coverage x-0.2-0.3 59.4%   
Debt to equity ratio x2.40.6 375.4%  
Sales to assets ratio x0.40.4 95.0%   
Return on assets %-0.811.8 -6.5%  
Return on equity %-146.9-0.8 17,378.6%  
Return on capital %-3.722.3 -16.7%  
Exports to sales %37.93.0 1,246.4%   
Imports to sales %22.60.4 5,295.5%   
Exports (fob) Rs m7,378307 2,406.3%   
Imports (cif) Rs m4,40643 10,223.0%   
Fx inflow Rs m7,513307 2,450.5%   
Fx outflow Rs m5,649125 4,508.2%   
Net fx Rs m1,865181 1,028.4%   
CASH FLOW
From Operations Rs m1,68211,754 14.3%  
From Investments Rs m-9,860-561 1,759.2%  
From Financial Activity Rs m6,644-6,762 -98.3%  
Net Cashflow Rs m-1,5354,432 -34.6%  

Share Holding

Indian Promoters % 32.3 39.6 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 7.5 61.3%  
FIIs % 3.3 16.8 19.6%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 36.1 153.2%  
Shareholders   84,811 16,479 514.7%  
Pledged promoter(s) holding % 54.9 77.6 70.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   AJANTA PHARMA  FDC LTD.  SHASUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Weak; FMCG Stocks Drag(12:30 pm)

Stock markets in India are trading in negative territory weighed by fast-moving consumer goods (FMCG) stocks.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Sep 26, 2018 02:55 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - ALEMBIC PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS